Percutaneous catheter ablation of atrial fibrillation

Expert Review of Cardiovascular Therapy

Volumn 5, Issue 4, 2007, Pages 693-705

  Daoud, Emile G ^a  

^a Ohio State University Medical Center ^*  (United States)

Author keywords

Antiarrhythmic; Atrial fibrillation; Catheter ablation; Clinical trial; Complications

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; PLACEBO;

ANTICOAGULANT THERAPY; CARDIOVERSION; CATHETER ABLATION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMPUTER ASSISTED THERAPY; COMPUTER ASSISTED TOMOGRAPHY; CRYOABLATION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; ECHOCARDIOGRAPHY; ESOPHAGUS FISTULA; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART PROARRHYTHMIA; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; INTERMETHOD COMPARISON; LASER SURGERY; LONG TERM CARE; MAXIMUM TOLERATED DOSE; MORBIDITY; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PATIENT SELECTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRACTICE GUIDELINE; PREVALENCE; PULMONARY VEIN; PULMONARY VEIN OBSTRUCTION; RADIOFREQUENCY ABLATION; REVIEW; STENT; THREE DIMENSIONAL IMAGING; THROMBOEMBOLISM; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; CONSTRICTION, PATHOLOGIC; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; ESOPHAGEAL FISTULA; HUMANS; IMAGING, THREE-DIMENSIONAL; PATIENT SELECTION; PULMONARY VEINS; RANDOMIZED CONTROLLED TRIALS; THROMBOEMBOLISM;

EID: 34447334793     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.5.4.693     Document Type: Review

References (79)

1. Roy D, Talajic M, Dorian P et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators. N. Engl. J. Med. 342, 913-920 (2000).
2. Nattel S, Lumer G, Tatajic M, Roy D. Cost evaluation of rhythm control methods for atrial fibrillation: evidence from CTAF: Card. Electrophysiol. Rev. 7, 211-214 (2003).
3. Gillinov AM. Advances in surgical treatment of atrial fibrillation. Stroke 38, 618-623 (2007).
4. Jalife J, Berenfeld O, Mansour M. Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation. Cardiovasc. Res. 54, 204-216 (2002).
5. Ausma J, van der Velden HM, Lenders MH et al. Reverse structural and gap-junctional remodeling after prolonged atrial fibrillation in the goat. Circulation 107, 2051-2058 (2003).
6. Thijssen VL, van der Velden HM, van Ankeren EP et al. Analysis of altered gene expression during sustained atrial fibrillation in the goat. Cardiovasc. Res. 54, 427-437 (2002).
7. Schotten U, Ausma J, Stellbrink C et al. Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation. Circulation 103, 691-698 (2001).
8. Ausma J, Coumans WA, Duimel H, Van der Vusse GJ, Allessie MA, Borgers M. Atrial high energy phosphate content and mitochondrial enzyme activity during chronic atrial fibrillation. Cardiovasc. Res. 47, 788-796 (2000).
9. van der Velden HM, Ausma J, Rook MB et al. Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. Cardiovasc. Res. 46, 476-486 (2000).
10. Thijssen VL, Ausma J, Liu GS, Allessie MA, van Eys GJ, Borgers M. Structural changes of atrial myocardium during chronic atrial fibrillation. Cardiovasc. Pathol. 9, 17-28 (2000).
11. Wijffels MC, Kirchhof CJ, Dorland R, Power J, Allessie MA. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohamoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation 96, 3710-3720 (1997).
12. Ausma J, Dispersyn GD, Duimel H et al. Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation. J. Mol. Cell. Cardiol. 32, 355-364 (2000).
13. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 92, 1954-1968 (1995).
14. Cheung DW. Pulmonary vein as an ectopic focus in a digitalis-induced arrhythmia. Nature 294, 582-584 (1981).
15. Scherf D. Studies on auricular tachycardia caused by aconitine administration. Proc. Soc. Exp. Biol. Med. 64, 233-239 (1947).
16. Haissaguerre M, Jais P, Shah DC et al. A focal source ofatrial fibrillation treated by discrete radiofrequency ablation. Circulation 95, 572-576 (1997).
17. Chen YJ, Chen SA, Chang MS, Lin CL. Arrhythmogenic activity of cardiac muscle in pulmonary veins of the dog: implication for the genesis of atrial fibrillation. Cardiovasc. Res. 48, 265-273 (2000).
18. Nathan H, Eliakim M. The junction between the left atrium and the pulmonary veins. An anatomic study of human hearts. Circulation 34, 412-422 (1966).
19. Kholova I, Kautzner J. Anatomic characteristics of extensions of atrial myocardium into the pulmonary veins in subjects with and without atrial fibrillation. Pacing Clin. Electrophyssol. 26, 1348-1355 (2003).
20. Lin WS, Prakash VS, Tai CT et al. Pulmonary vein morphology in patients with paroxysmal atrial fibrillation initiated by ectopic beats originating from the pulmonary veins: implications for catheter ablation. Circulation 101, 1274-1281 (2000).
21. Sanders P, Berenfeld O, Hocini M et al. Spectral analysis identifies sites of high-frequency gradient in paroxysmal but no persistent atrial fibrillation in humans. Circulation 110, 3181-3186 (2004).
22. Martin RE, Ellenbogen KA, Lau YR et al. Phased-array intracardiac echocardiography during pulmonary vein isolation and linear ablation for atrial fibrillation. J. Cardiovasc. Electrophysiol. 13, 873-879 (2002).
23. Tada H, Oral H, Ozaydin M et al. Response of pulmonary vein potentials to premature stimulation. J. Cardiovasc. Electrophysiol. 13, 33-37 (2002).
24. Nakashima H, Kumagai K, Noguchi H, Tojo H, Yasuda T, Saku K. Evaluation of the recurrence of atrial fibrillation after pulmonary venous ablation. J. Cardiol. 40, 87-94 (2002).
25. Haissaguerre M, Jais P, Shah DC et al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 101, 1409-1417 (2000).
26. Pappone C, Oreto G, Rosanio S et al. Atrial electro-anatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation 104, 2539-2544 (2001).
27. Daoud EG, Weiss R, Augostini R et al. Proarrhythmia of circumferential left atrial lesions for management of atrial fibrillation. J. Cardiovasc. Electrophysiol. 17, 157-165 (2006).
28. Khaykin Y, Marrouche NF, Saliba W et al. Pulmonary vein antrum isolation for treatment of atrial fibrillation in patients with valvular heart disease or prior open heart surgery. Heart Rhythm 1, 33-39 (2004).
29. Ouyang F, Ernst S, Chun J et al. Electrophysiological findings during ablation of persistent atrial fibrillation with electroanatomic mapping and double Lasso catheter technique. Circulation 112, 3038-3048 (2005).
30. Kanj MH, Wazni O, Fahmy T et al. Pulmonary vein antral isolation using an open irrigation ablation catheter for the treatment of atrial fibrillation: a randomized pilot study. J. Am. Coll. Cardiol. 49, 1634-1641 (2007).
31. Marrouche NF, Guenther J, Segerson NM et al. Randomized comparison between open irrigation technology and intracardiac-echo-guided energy delivery for pulmonary vein antrum isolation: procedural parameters, outcomes, and the effect on esophageal injury. J. Cardiovasc. Electrophysiol. 18(6), 583-588 (2007).
32. Kanj M, Wazni O, Natale A. Pulmonary vein antrum isolation. Heart Rhythm 4, S73-S79 (2007).
33. Nadamanee K, McKenzie J, Koser E et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J. Am. Coll. Cardiol. 43, 2054-2060 (2004).
34. Scherlag BJ, Yamanashi WS, Patel U, Lazzara R, Jackman WM. Autonomically induced conversion of pulmonary vein focal firing into atrial fibrillation. J. Am. Coll. Cardiol. 45, 1878-1882 (2005).
35. Scherlag BJ, Patterson E, Po SS. The neural basis of atrial fibrillation. J. Electrocardiol. 39, S180-S183 (2006).
36. Pappone C, Santinelli V, Manguso F et al. Pulmonary vein denervation enhances long-term benefit after circumferential ablation for paroxysmal atrial fibrillation. Circulation 109, 327-334 (2004).
37. Oral H, Scharf C, Chugh A et al. Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation 108, 2355-2360 (2003).
38. Karch MR, Zrenner B, Deisenhofer I et al. Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies. Circulation 111, 2875-2880 (2005).
39. Jais P, Hocinic M, Hsu LF et al. Technique and results of linear ablation at the mitral isthmus. Circulation 110, 2996-3002 (2004).
40. Hocini M, Jais P, Sanders P et al. Techniques, evaluation and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation. Circulation 112, 3688-3696 (2005).
41. Sanders P, Jais P, Hocinic M et al. Electrophysiologic an clinic consequences of linear catheter ablation to transect the anterior left atrium in patients with atrial fibrillation. Heart Rhythm 1, 176-184 (2004).
42. Calo L, Lamberti F, Loricchio ML et al. Left atrial ablation versus biatrial ablation for persistent and permanent atrial fibrillation. J. Am. Coll. Cardiol. 47, 2504-2512 (2006).
43. Oral H, Chugh A, Good E et al. A tailored approach to catheter ablation of paroxysmal atrial fibrillation. Circulation 113, 1824-1831 (2006).
44. Cappato R, Calkins H, Chen SA et al. Worldwide survey on the methods, efficacy and safety of catheter ablation for human atrial fibrillation. Circulation 111, 1100-1105 (2005).
45. Verma A, Natale A. Should atrial fibrillation ablation be considered first-line therapy for some patients? Circulation 112, 1214-1222 (2005).
46. Cauchemez B, Extramiana F, Cauchemez S et al. High flow perfusion of sheaths for prevention of thromboembolic complications during complex catheter ablation in the left atrium. J. Cardiovasc. Electrophysiol. 15, 276-283 (2004).
47. Ren JF, Marchilinski FE, Callans DJ et al. Increased intensity of anticoagulation may reduce risk of thrombus during atrial fibrillation ablation procedures in patients with spontaneous echo contrast. J. Cardiovasc. Electrophysiol. 16, 474-477 (2005).
48. Robbins IM, Colvin EV, Doyle TP et al. Pulmonary vein stenosis after catheter ablation of atrial fibrillation. Circulation 98, 1769-1775 (1998).
49. Packer DL, Keelan P, Munger TM et al. Clinical presentation, investigation and management of pulmonary vein stenosis complicating ablation of atrial fibrillation. Circulation 16, 1180-1188 (2005).
50. Pappone C, Oral H, Santinelli V et al. Atrioesophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation 109, 2724-2726 (2004).
51. Dagres N, Kottkamp H, Piorkowski C et al. Rapid detection and successful treatment of esophageal perforation after radiofrequency ablation of atrial fibrillation: lessons from five cases. J. Cardiovasc. Eletrophysiol. 17, 1213-1215 (2006).
52. Mesas CE, Pappone C, Lang CCE et al. Left atrial tachycardia after circumferential pulmonary vein ablation for atrial fibrillation. J. Am. Coll. Cardiol. 4, 1071-1079 (2004).
53. Lustgarten DL, Keane D, Ruskin J. Cryothermal ablation: mechanism of tissue injury and current experience in the treatment of tachyarrhythmias. Prog. Cardiovasc. Dis. 41, 481-598 (1999).
54. Skanes AC, Jensen SM, Papp R et al. Isolation of pulmonary veins using a transvenous curvilinear cryoablation catheter: feasibility, initial experience and analysis of recurrences. J. Cardiovasc. Electrophysiol. 16, 1304-1308 (2005).
55. Yiu KH, Lau CP, Lee KL, Tse HF. Emerging energy sources for catheter ablation of atrial fibrillation. J. Cardiovasc. Electrophysiol. 17, S56-S61 (2006).
56. Nakagawa H, Antz M, Wong T et al. Initial experience using a forward directed, high-intensity focused ultrasound balloon catheter for pulmonary vein antrum isolation in patients with atrial fibrillation. J. Cardiovasc. Electrophysiol. 18, 136-144 (2007).
57. Reddy VY, Houghtaling C, Fallon J et al. Use of a diode laser balloon ablation catheter to generate circumferential pulmonary venous lesions in an open-thoracotomy caprine model. Pacing Clin. Electrophysiol. 27, 52-57 (2004).
58. Daoud E, Kalbfleisch S, Hummel J. Intracardiac echocardiography to guide trans-septal left heart catheterization for radiofrequency catheter ablation. J. Cardiovasc. Electrophysiol. 10, 358-363 (1999).
59. Ren JF, Marchlinski FE, Callans DJ. Left atrial thrombus associated with ablation for atrial fibrillation: identification with intracardiac echocardiography. J. Am. Coll. Cardiol. 43, 1861-1867 (2004).
60. Mangrum JM, Mounsey JP, Kok LC, DiMarco JP, Haines DE. Intracardiac echocardiography-guided, anatomically based radiofrequency ablation of focal atrial fibrillation originating from pulmonary veins. J. Am. Coll. Cardiol. 39, 1964-1969 (2002).
61. Pappone G, Vicedomini G, Manguso F et al. Robotic magnetic navigation for atrial fibrillation ablation. J. Am. Coll. Cardiol. 47, 1390-1400 (2006).
62. Wyse DG, Waldo AL, DiMarco JP et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. N. Engl. J. Med. 347, 1825-1833 (2002).
63. Epstein AE, Corley SD. Relationship between sinus rhythm, treatment and survival in the Atrial Fibrillation Follow-up Investigation Of Rhythm Management (AFFIRM) study. Circulation 109, 1509-1513 (2003).
64. Pappone C, Rosanio S, Augello G et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J. Am. Coll. Cardiol. 42, 185-197 (2003).
65. Pappone C, Augello G, Sala S et al. A randomized trial of circumferential pulmonary vein ablation versus Antiarrhythmic drug therapy in Paroxysmal Atrial Fibrillation: the APAF Study. J. Am. Coll. Cardiol. 48, 2340-2347 (2006).
66. Jais P, Cauchemez B, Macle L, Daoud E, Waldo A, Ruskin J. Atrial fibrillation ablation vs antiarrhythmic drugs: a multicenter randomized trial. Heart Rhythm 3, 1126 (2006).
67. Fuster V, Ryden LE, Cannom DS et al. ACC/AHA/ESC 2006 guidelines management of patients with atrial fibrillation. Circulation 114, 257-354 (2006).
68. Wazni OM, Marrouche NF, Martin DO et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 293, 2634-2640 (2005).
69. Knight BP, Oral H, Chugh A et al. Effects of operator experience on the outcome and duration of pulmonary vein isolation. Am. J. Cardiol. 91, 673-677 (2003).
70. Haissaguerre M, Jais P, Shah DC et al. Electrophysiology end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. Circulation 101, 1409-1417 (2000).
71. Marrouche NF, Dresing T, Cole C et al. Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation: impact of different catheter technologies. J. Am. Coll. Cardiol. 40, 464-474 (2002).
72. Oral H, Knight B, Ozaydin M et al. Segmental ostial ablation to isolate the pulmonary veins during atrial fibrillation: feasibility and mechanistic insights. Circulation 106, 1256-1262 (2002).
73. Deisenhofer I, Schneider MA, Bohlen-Knauf M et al. Circumferential mapping and electric isolation of pulmonary veins in patients with atrial fibrillation. Am. J. Cardiol. 91, 159-163 (2003).
74. Arentz T, von Rosenthal J, Blum T et al. Feasibility and safety of pulmonary vein isolation using a new mapping and navigation system in patients with refractory atrial fibrillation. Circulation 108, 2484-2490 (2003).
75. Vasamreddy CR, Dalal D, Eldadah Z et al. Safety and efficacy of circumferential pulmonary vein catheter ablation of atrial fibrillation. Heart Rhythm 2, 42-48 (2005).
76. Mansour M, Ruskin J, Keane D. Efficacy and safety of segmental ostial versus circumferential extra-ostial pulmonary vein isolation for atrial fibrillation. J. Cardiovasc. Electrophysiol. 15, 532-537 (2004).
77. Kanagaratnam L, Tomassoni G, Schweikert R et al. Empirical pulmonary vein isolation in patients with chronic atrial fibrillation using a three-dimensional nonfluoroscopic mapping system: long-term follow-up. Pacing Clin. Electrophysiol. 24, 1774-1779 (2001).
78. Kottkamp H, Tanner H, Kobza R et al. Time courses and quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions: trigger elimination or substrate modification: early or delayed cure? J. Am. Coll. Cardiol. 44, 869-877 (2004).
79. Oral H, Pappone C, Chugh A et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N. Engl. J. Med. 354, 934-941 (2006).